TA
HAE icon

Teton Advisors’s Haemonetics HAE Stock Holding History

Teton Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,400
Closed -$233K – 345
2021
Q4 		$233K Hold
4,400
– – 0.03% 363
2021
Q3 		$311K Buy
4,400
+300
+7% +$18.9K 0.05% 333
2021
Q2 		$273K Buy
+4,100
New +$290K 0.04% 350

Other funds holding HAE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Teton Advisors's HAE Position: Q1 2022 in Review

Teton Advisors sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 4,400 shares — an estimated $233K sold.

Teton Advisors first reported a position in HAE in Q2 2021 and held it in 3 quarters. The position peaked at $311K in Q3 2021. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • Teton Advisors reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
  • Teton Advisors sold 4,400 Haemonetics shares in Q1 2022, an estimated $233K.
  • Teton Advisors first reported a position in Haemonetics in Q2 2021 and held it in 3 quarters.
  • Teton Advisors's Haemonetics position peaked at $311K in Q3 2021.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Teton Advisors's 13F filing for Q1 2022, filed 13 May 2022.